The Europe Cell Therapy Market would witness market growth of 25.3% CAGR during the forecast period (2020-2026). The arrival of modern technologies has encouraged the development of advanced cellular therapies growth.
Companies are using the latest technologies with an aim to increase their product offerings and set-up out-licensing or co-development agreements with other bodies to encourage their product development programs.
Cell-based therapies have the power for substituting, repairing, restoring, or regenerating damaged tissues, and organs. Researchers are putting huge investments in the development of these effective and secure treatments as an option to traditional treatment strategies which can be further supporting the market growth. Among all therapeutic segments, oncology has the biggest number of ongoing clinical trials. For the clinical investigation, mesenchymal stem/stromal cells, CD34+ and/or CD133+ cells, and T cells are used.
The surge in occurrences of the population suffering from cardiovascular, cancer, and other diseases are anticipated to boost the growth of the market. In addition, increasing initiatives undertook by authorities and governments to enhance healthcare systems and spread awareness about the advantages of cell therapy are also anticipated to push the development of the market growth.
The increasing number of clinical studies for cell-based therapies is boosting the growth of the market. This has brought considerable global funding in R&D and their clinical translation. The rising number of ongoing clinical trials is the result of the existence of government and private funding agencies that are consistently providing investments to promote projects across several phases of clinical trials.
The Germany market dominated the Europe Musculoskeletal Disorders Market by Country 2019, growing at a CAGR of 24.9 % during the forecast period. The UK market is exhibiting a CAGR of 25.3% during (2020 - 2026). Additionally, The France market is anticipated to witness a CAGR of 27.1% during (2020 - 2026).
The Academic & Research Institutes market dominated the Russia Cell Therapy Market by End User 2019, thereby, achieving a market value of $682.5 million by 2026. The Hospitals & Clinics market is expected to witness highest CAGR of 26.5% during (2020 - 2026).
Based on Therapy Type, the market is segmented into Autologous and Allogeneic. Based on Therapeutic Area, the market is segmented into Malignancies, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology and Others. Based on End User, the market is segmented into Academic & Research Institutes and Hospitals & Clinics. Based on Cell Type, the market is segmented into Stem Cell, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Non-Stem Cell, Bone Marrow, Blood and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: Cell Therapy Market in Europe is expected to register a CAGR of 25.3% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujifilm Holdings Corporation, Smith & Nephew PLC, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Medipost Co., Ltd., Stemedica Cell Technologies, Inc., NuVasive, Inc., Avantor, Inc., Vericel Corporation, and Pharmicell Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
By Therapeutic Area
- Malignancies
- Autoimmune Disorders
- Musculoskeletal Disorders
- Dermatology
- Others
By End User
- Academic & Research Institutes
- Hospitals & Clinics
By Cell Type
- Stem Cell
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Non-Stem Cell
- Bone Marrow
- Blood
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Fujifilm Holdings Corporation
- Smith & Nephew PLC
- Kolon TissueGene, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Medipost Co., Ltd.
- Stemedica Cell Technologies, Inc.
- NuVasive, Inc.
- Avantor, Inc.
- Vericel Corporation
- Pharmicell Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cell Therapy Market, by Therapy Type
1.4.2 Europe Cell Therapy Market, by Therapeutic Area
1.4.3 Europe Cell Therapy Market, by End User
1.4.4 Europe Cell Therapy Market, by Cell Type
1.4.5 Europe Cell Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals & Trials
3.2.5 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Europe Cell Therapy Market by Therapy Type
4.1 Europe Autologous Market by Country
4.2 Europe Allogeneic Market by Country
Chapter 5. Europe Cell Therapy Market by Therapeutic Area
5.1 Europe Malignancies Market by Country
5.2 Europe Autoimmune Disorders Market by Country
5.3 Europe Musculoskeletal Disorders Market by Country
5.4 Europe Dermatology Market by Country
5.5 Europe Other Therapeutic Area Market by Country
Chapter 6. Europe Cell Therapy Market by End User
6.1 Europe Academic & Research Institutes Market by Country
6.2 Europe Hospitals & Clinics Market by Country
Chapter 7. Europe Cell Therapy Market by Cell Type
7.1 Europe Stem Cell Market by Country
7.2 Europe Umbilical Cord-Derived Cell Market by Country
7.3 Europe Adipose-Derived Stem Cell Market by Country
7.4 Europe Non-Stem Cell Market by Country
7.5 Europe Bone Marrow Cell Market by Country
7.6 Europe Blood Cell Market by Country
7.7 Europe Others Cell Market by Country
Chapter 8. Europe Cell Therapy Market by Country
8.1 Germany Cell Therapy Market
8.1.1 Germany Cell Therapy Market by Therapy Type
8.1.2 Germany Cell Therapy Market by Therapeutic Area
8.1.3 Germany Cell Therapy Market by End User
8.1.4 Germany Cell Therapy Market by Cell Type
8.2 UK Cell Therapy Market
8.2.1 UK Cell Therapy Market by Therapy Type
8.2.2 UK Cell Therapy Market by Therapeutic Area
8.2.3 UK Cell Therapy Market by End User
8.2.4 UK Cell Therapy Market by Cell Type
8.3 France Cell Therapy Market
8.3.1 France Cell Therapy Market by Therapy Type
8.3.2 France Cell Therapy Market by Therapeutic Area
8.3.3 France Cell Therapy Market by End User
8.3.4 France Cell Therapy Market by Cell Type
8.4 Russia Cell Therapy Market
8.4.1 Russia Cell Therapy Market by Therapy Type
8.4.2 Russia Cell Therapy Market by Therapeutic Area
8.4.3 Russia Cell Therapy Market by End User
8.4.4 Russia Cell Therapy Market by Cell Type
8.5 Spain Cell Therapy Market
8.5.1 Spain Cell Therapy Market by Therapy Type
8.5.2 Spain Cell Therapy Market by Therapeutic Area
8.5.3 Spain Cell Therapy Market by End User
8.5.4 Spain Cell Therapy Market by Cell Type
8.6 Italy Cell Therapy Market
8.6.1 Italy Cell Therapy Market by Therapy Type
8.6.2 Italy Cell Therapy Market by Therapeutic Area
8.6.3 Italy Cell Therapy Market by End User
8.6.4 Italy Cell Therapy Market by Cell Type
8.7 Rest of Europe Cell Therapy Market
8.7.1 Rest of Europe Cell Therapy Market by Therapy Type
8.7.2 Rest of Europe Cell Therapy Market by Therapeutic Area
8.7.3 Rest of Europe Cell Therapy Market by End User
8.7.4 Rest of Europe Cell Therapy Market by Cell Type
Chapter 9. Company Profiles
9.1 Fujifilm Holdings Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.2 Smith & Nephew PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Kolon TissueGene, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Approvals & Trials:
9.4 JCR Pharmaceuticals Co., Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Acquisition and Mergers:
9.4.4.3 Approvals & Trials:
9.5 Medipost Co., Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Partnerships, Collaborations, and Agreements:
9.5.3.2 Approvals & Trials:
9.6 Stemedica Cell Technologies, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Approvals & Trials:
9.7 NuVasive, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Geographical Expansions:
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. Pharmicell Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expense
9.10.4 Recent strategies and developments:
9.10.4.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Europe Cell Therapy Market, 2016 - 2019, USD Million
TABLE 2 Europe Cell Therapy Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cell Therapy Market
TABLE 4 Product Launches And Product Expansions– Cell Therapy Market
TABLE 5 Geographical Expansions– Cell Therapy Market
TABLE 6 Approvals & Trials– Cell Therapy Market
TABLE 7 Acquisition and Mergers– Cell Therapy Market
TABLE 8 Europe Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 9 Europe Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 10 Europe Autologous Market by Country, 2016 - 2019, USD Million
TABLE 11 Europe Autologous Market by Country, 2020 - 2026, USD Million
TABLE 12 Europe Allogeneic Market by Country, 2016 - 2019, USD Million
TABLE 13 Europe Allogeneic Market by Country, 2020 - 2026, USD Million
TABLE 14 Europe Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 15 Europe Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 16 Europe Malignancies Market by Country, 2016 - 2019, USD Million
TABLE 17 Europe Malignancies Market by Country, 2020 - 2026, USD Million
TABLE 18 Europe Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
TABLE 19 Europe Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
TABLE 20 Europe Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
TABLE 21 Europe Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
TABLE 22 Europe Dermatology Market by Country, 2016 - 2019, USD Million
TABLE 23 Europe Dermatology Market by Country, 2020 - 2026, USD Million
TABLE 24 Europe Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
TABLE 25 Europe Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
TABLE 26 Europe Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 27 Europe Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 28 Europe Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
TABLE 29 Europe Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
TABLE 30 Europe Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
TABLE 31 Europe Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
TABLE 32 Europe Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 33 Europe Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 34 Europe Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 35 Europe Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 36 Europe Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
TABLE 37 Europe Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
TABLE 38 Europe Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 39 Europe Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 40 Europe Non-Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 41 Europe Non-Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 42 Europe Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
TABLE 43 Europe Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
TABLE 44 Europe Blood Cell Market by Country, 2016 - 2019, USD Million
TABLE 45 Europe Blood Cell Market by Country, 2020 - 2026, USD Million
TABLE 46 Europe Others Cell Market by Country, 2016 - 2019, USD Million
TABLE 47 Europe Others Cell Market by Country, 2020 - 2026, USD Million
TABLE 48 Europe Cell Therapy Market by Country, 2016 - 2019, USD Million
TABLE 49 Europe Cell Therapy Market by Country, 2020 - 2026, USD Million
TABLE 50 Germany Cell Therapy Market, 2016 - 2019, USD Million
TABLE 51 Germany Cell Therapy Market, 2020 - 2026, USD Million
TABLE 52 Germany Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 53 Germany Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 54 Germany Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 55 Germany Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 56 Germany Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 57 Germany Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 58 Germany Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 59 Germany Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 60 UK Cell Therapy Market, 2016 - 2019, USD Million
TABLE 61 UK Cell Therapy Market, 2020 - 2026, USD Million
TABLE 62 UK Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 63 UK Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 64 UK Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 65 UK Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 66 UK Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 67 UK Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 68 UK Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 69 UK Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 70 France Cell Therapy Market, 2016 - 2019, USD Million
TABLE 71 France Cell Therapy Market, 2020 - 2026, USD Million
TABLE 72 France Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 73 France Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 74 France Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 75 France Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 76 France Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 77 France Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 78 France Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 79 France Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 80 Russia Cell Therapy Market, 2016 - 2019, USD Million
TABLE 81 Russia Cell Therapy Market, 2020 - 2026, USD Million
TABLE 82 Russia Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 83 Russia Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 84 Russia Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 85 Russia Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 86 Russia Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 87 Russia Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 88 Russia Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 89 Russia Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 90 Spain Cell Therapy Market, 2016 - 2019, USD Million
TABLE 91 Spain Cell Therapy Market, 2020 - 2026, USD Million
TABLE 92 Spain Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 93 Spain Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 94 Spain Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 95 Spain Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 96 Spain Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 97 Spain Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 98 Spain Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 99 Spain Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 100 Italy Cell Therapy Market, 2016 - 2019, USD Million
TABLE 101 Italy Cell Therapy Market, 2020 - 2026, USD Million
TABLE 102 Italy Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 103 Italy Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 104 Italy Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 105 Italy Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 106 Italy Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 107 Italy Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 108 Italy Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 109 Italy Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 110 Rest of Europe Cell Therapy Market, 2016 - 2019, USD Million
TABLE 111 Rest of Europe Cell Therapy Market, 2020 - 2026, USD Million
TABLE 112 Rest of Europe Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 113 Rest of Europe Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 114 Rest of Europe Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 115 Rest of Europe Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 116 Rest of Europe Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 117 Rest of Europe Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 118 Rest of Europe Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 119 Rest of Europe Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 120 Key Information – Fujifilm Holdings Corporation
TABLE 121 key Information – Smith & Nephew PLC
TABLE 122 key information – Kolon TissueGene, Inc.
TABLE 123 Key Information – JCR Pharmaceuticals Co., Ltd.
TABLE 124 Key Information – Medipost Co., Ltd.
TABLE 125 key Information – Stemedica Cell Technologies, Inc.
TABLE 126 Key Information – NuVasive, Inc.
TABLE 127 key information – Avantor, Inc.
TABLE 128 Key Information – Vericel Corporation
TABLE 129 Key Information – Pharmicell Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Fujifilm Holdings Corporation
FIG 5 Recent strategies and developments: Smith & Nephew PLC
FIG 6 Recent strategies and developments: JCR Pharmaceuticals Co., Ltd.
FIG 7 Recent strategies and developments: Avantor, Inc.
FIG 8 Recent strategies and developments: Vericel Corporation